Maureen Galmes-Spit

Company: Laigo Bio

Job title: Vice President - Research

Seminars:

SureTACsTM: Beyond Blocking Membrane Proteins 11:30 am

Membrane-bound E3 ligases can be repurposed for the targeted degradation of disease-driving cell surface proteins Laigo Bio’s TED-I screening platform is essential to identify optimal E3-target pairs with highest degrader potency SureTACsTM: bispecific antibodies that induce cell surface removal and target degradation in a tissue- and disease-specific mannerRead more

day: Day 2, Track 2, AM